TEVA logo

TEVA Retained earnings

annual retained earnings:

-$15.17B-$1.64B(-12.11%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual retained earnings is -$15.17 billion, with the most recent change of -$1.64 billion (-12.11%) on December 31, 2024.
  • During the last 3 years, TEVA annual retained earnings has fallen by -$4.64 billion (-44.11%).
  • TEVA annual retained earnings is now -202.17% below its all-time high of $14.85 billion, reached on December 31, 2015.

Performance

TEVA Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly retained earnings:

-$14.96B+$215.00M(+1.42%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly retained earnings is -$14.96 billion, with the most recent change of +$215.00 million (+1.42%) on March 31, 2025.
  • Over the past year, TEVA quarterly retained earnings has dropped by -$1.28 billion (-9.40%).
  • TEVA quarterly retained earnings is now -198.99% below its all-time high of $15.11 billion, reached on March 31, 2016.

Performance

TEVA quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TEVA Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.1%-9.4%
3 y3 years-44.1%-30.3%
5 y5 years-118.1%-117.2%

TEVA Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-44.1%at low-30.3%+1.4%
5 y5-year-118.1%at low-121.7%+1.4%
alltimeall time-202.2%at low-199.0%+1.4%

TEVA Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$14.96B(-1.4%)
Dec 2024
-$15.17B(+12.1%)
-$15.17B(+1.5%)
Sep 2024
-
-$14.96B(+3.0%)
Jun 2024
-
-$14.52B(+6.2%)
Mar 2024
-
-$13.67B(+1.0%)
Dec 2023
-$13.53B(+4.3%)
-$13.53B(-2.4%)
Sep 2023
-
-$13.87B(-0.6%)
Jun 2023
-
-$13.95B(+6.6%)
Mar 2023
-
-$13.09B(+0.9%)
Dec 2022
-$12.97B(+23.2%)
-$12.97B(+11.3%)
Sep 2022
-
-$11.66B(-0.5%)
Jun 2022
-
-$11.72B(+2.0%)
Mar 2022
-
-$11.48B(+9.1%)
Dec 2021
-$10.53B(-3.8%)
-$10.53B(+1.5%)
Sep 2021
-
-$10.37B(-2.7%)
Jun 2021
-
-$10.66B(-1.9%)
Mar 2021
-
-$10.87B(-0.7%)
Dec 2020
-$10.95B(+57.4%)
-$10.95B(-1.4%)
Sep 2020
-
-$11.10B(+64.5%)
Jun 2020
-
-$6.75B(-2.0%)
Mar 2020
-
-$6.89B(-1.0%)
Dec 2019
-$6.96B(+16.8%)
-$6.96B(-1.6%)
Sep 2019
-
-$7.07B(+4.7%)
Jun 2019
-
-$6.75B(+11.4%)
Mar 2019
-
-$6.06B(+1.8%)
Dec 2018
-$5.96B(+56.7%)
-$5.96B(+93.9%)
Sep 2018
-
-$3.07B(+7.3%)
Jun 2018
-
-$2.86B(+6.5%)
Mar 2018
-
-$2.69B(-29.3%)
Dec 2017
-$3.80B(-127.9%)
-$3.80B(-148.3%)
Sep 2017
-
$7.87B(+6.0%)
Jun 2017
-
$7.43B(-46.2%)
Mar 2017
-
$13.81B(+1.5%)
Dec 2016
$13.61B(-8.4%)
$13.61B(-9.2%)
Sep 2016
-
$14.99B(+0.0%)
Jun 2016
-
$14.99B(-0.8%)
Mar 2016
-
$15.11B(+1.7%)
Dec 2015
$14.85B(+2.9%)
$14.85B(+1.3%)
Sep 2015
-
$14.66B(-1.2%)
Jun 2015
-
$14.84B(+1.7%)
Mar 2015
-
$14.59B(+1.1%)
Dec 2014
$14.44B(+15.2%)
$14.44B(+3.0%)
Sep 2014
-
$14.02B(+4.3%)
Jun 2014
-
$13.44B(+3.5%)
Mar 2014
-
$12.99B(+3.6%)
Dec 2013
$12.54B(+1.5%)
$12.54B(+0.8%)
Sep 2013
-
$12.43B(+3.7%)
Jun 2013
-
$11.99B(-5.7%)
Mar 2013
-
$12.71B(+2.9%)
Dec 2012
$12.35B(+9.4%)
$12.35B(+0.8%)
Sep 2012
-
$12.25B(-2.3%)
Jun 2012
-
$12.54B(+5.3%)
Mar 2012
-
$11.91B(+5.5%)
Dec 2011
$11.28B(+21.0%)
$11.28B(+2.9%)
Sep 2011
-
$10.97B(+6.9%)
Jun 2011
-
$10.26B(+3.8%)
Mar 2011
-
$9.88B(+6.0%)
Dec 2010
$9.32B
$9.32B(+6.9%)
Sep 2010
-
$8.73B(+11.3%)
DateAnnualQuarterly
Jun 2010
-
$7.84B(+17.7%)
Dec 2009
$6.66B(+26.0%)
$6.66B(+12.9%)
Jun 2009
-
$5.90B(+7.0%)
Mar 2009
-
$5.51B(+4.3%)
Dec 2008
$5.29B(+4.9%)
$5.29B(-12.8%)
Sep 2008
-
$6.07B(+9.8%)
Jun 2008
-
$5.53B(+8.5%)
Mar 2008
-
$5.09B(+1.0%)
Dec 2007
$5.04B(+48.4%)
$5.04B(+10.8%)
Sep 2007
-
$4.55B(+11.0%)
Jun 2007
-
$4.10B(+11.8%)
Mar 2007
-
$3.67B(+7.9%)
Dec 2006
$3.40B(+10.3%)
$3.40B(+13.3%)
Sep 2006
-
$3.00B(+22.4%)
Jun 2006
-
$2.45B(+21.4%)
Mar 2006
-
$2.02B(-34.5%)
Dec 2005
$3.08B(+42.0%)
$3.08B(+9.5%)
Sep 2005
-
$2.82B(+8.8%)
Jun 2005
-
$2.59B(+8.4%)
Mar 2005
-
$2.39B(+10.0%)
Dec 2004
$2.17B(+10.7%)
$2.17B(+13.2%)
Sep 2004
-
$1.92B(+13.0%)
Jun 2004
-
$1.70B(+12.9%)
Mar 2004
-
$1.50B(-23.4%)
Dec 2003
$1.96B(+45.7%)
$1.96B(+9.3%)
Sep 2003
-
$1.79B(+8.3%)
Jun 2003
-
$1.66B(+13.1%)
Mar 2003
-
$1.47B(+8.9%)
Dec 2002
$1.35B(+38.7%)
$1.35B(+11.2%)
Sep 2002
-
$1.21B(+7.5%)
Jun 2002
-
$1.13B(+7.8%)
Mar 2002
-
$1.04B(+7.6%)
Dec 2001
$970.42M(+33.2%)
$970.42M(+7.5%)
Sep 2001
-
$902.80M(+8.6%)
Jun 2001
-
$831.31M(+7.3%)
Mar 2001
-
$774.96M(+6.4%)
Dec 2000
$728.34M(+19.6%)
$728.34M(+4.4%)
Sep 2000
-
$697.43M(+9.5%)
Jun 2000
-
$637.05M(-0.7%)
Mar 2000
-
$641.83M(+5.4%)
Dec 1999
$608.91M(+20.3%)
$608.91M(-0.6%)
Sep 1999
-
$612.30M(+3.1%)
Jun 1999
-
$593.90M(+5.5%)
Mar 1999
-
$562.80M(+11.2%)
Dec 1998
$506.10M(+10.8%)
$506.10M(-3.4%)
Sep 1998
-
$524.10M(+5.1%)
Jun 1998
-
$498.90M(+3.5%)
Mar 1998
-
$481.80M(+5.5%)
Dec 1997
$456.70M(+21.3%)
$456.70M(+21.3%)
Dec 1996
$376.40M(+17.7%)
$376.40M(+17.7%)
Dec 1995
$319.80M(+47.2%)
$319.80M(+47.2%)
Dec 1994
$217.30M(+35.9%)
$217.30M(+35.9%)
Dec 1993
$159.90M(+37.1%)
$159.90M(+37.1%)
Dec 1992
$116.60M(+30.6%)
$116.60M(+30.6%)
Dec 1991
$89.30M(+16.4%)
$89.30M(+16.4%)
Dec 1990
$76.70M(+35.3%)
$76.70M(+35.3%)
Dec 1989
$56.70M(+36.3%)
$56.70M(+36.3%)
Dec 1988
$41.60M(+74.1%)
$41.60M(+74.1%)
Mar 1987
$23.90M(+1.3%)
$23.90M(+1.3%)
Mar 1986
$23.60M
$23.60M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual retained earnings?
  • What is the all time high annual retained earnings for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual retained earnings year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly retained earnings year-on-year change?

What is Teva Pharmaceutical Industries Limited annual retained earnings?

The current annual retained earnings of TEVA is -$15.17B

What is the all time high annual retained earnings for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual retained earnings is $14.85B

What is Teva Pharmaceutical Industries Limited annual retained earnings year-on-year change?

Over the past year, TEVA annual retained earnings has changed by -$1.64B (-12.11%)

What is Teva Pharmaceutical Industries Limited quarterly retained earnings?

The current quarterly retained earnings of TEVA is -$14.96B

What is the all time high quarterly retained earnings for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly retained earnings is $15.11B

What is Teva Pharmaceutical Industries Limited quarterly retained earnings year-on-year change?

Over the past year, TEVA quarterly retained earnings has changed by -$1.28B (-9.40%)
On this page